| 1 |
31571629 | Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction. | 2019 Jul |
1 |
| 2 |
29279531 | Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome. | 2018 Jan 27 |
1 |
| 3 |
29615454 | Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. | 2018 Apr |
2 |
| 4 |
29743380 | Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction　- The CALDERA-GENE Study. | 2018 May 25 |
1 |
| 5 |
30188374 | Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians. | 2018 Sep |
2 |
| 6 |
25851472 | Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation. | 2016 Jan |
1 |
| 7 |
26815196 | Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity. | 2016 Jan 27 |
1 |
| 8 |
24088578 | Impact of CYP2C19 polymorphism on platelet function tests and coagulation and inflammatory biomarkers in patients undergoing percutaneous coronary intervention. | 2014 |
1 |
| 9 |
21392617 | The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy. | 2011 Mar |
1 |